U.S. flag

An official website of the United States government

NM_153033.5(KCTD7):c.550C>T (p.Arg184Cys) AND Inborn genetic diseases

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 28, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002513270.3

Allele description [Variation Report for NM_153033.5(KCTD7):c.550C>T (p.Arg184Cys)]

NM_153033.5(KCTD7):c.550C>T (p.Arg184Cys)

Gene:
KCTD7:potassium channel tetramerization domain containing 7 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q11.21
Genomic location:
Preferred name:
NM_153033.5(KCTD7):c.550C>T (p.Arg184Cys)
HGVS:
  • NC_000007.14:g.66638912C>T
  • NG_028110.2:g.15032C>T
  • NM_001167961.2:c.550C>T
  • NM_153033.5:c.550C>TMANE SELECT
  • NP_001161433.1:p.Arg184Cys
  • NP_694578.1:p.Arg184Cys
  • NP_694578.1:p.Arg184Cys
  • LRG_835t1:c.550C>T
  • LRG_835:g.15032C>T
  • LRG_835p1:p.Arg184Cys
  • NC_000007.13:g.66103899C>T
  • NM_153033.4:c.550C>T
  • Q96MP8:p.Arg184Cys
Protein change:
R184C; ARG184CYS
Links:
UniProtKB: Q96MP8#VAR_068779; OMIM: 611725.0002; dbSNP: rs387907246
NCBI 1000 Genomes Browser:
rs387907246
Molecular consequence:
  • NM_001167961.2:c.550C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153033.5:c.550C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003556778Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Feb 28, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.

Staropoli JF, Karaa A, Lim ET, Kirby A, Elbalalesy N, Romansky SG, Leydiker KB, Coppel SH, Barone R, Xin W, MacDonald ME, Abdenur JE, Daly MJ, Sims KB, Cotman SL.

Am J Hum Genet. 2012 Jul 13;91(1):202-8. doi: 10.1016/j.ajhg.2012.05.023. Epub 2012 Jun 28.

PubMed [citation]
PMID:
22748208
PMCID:
PMC3397260

Pathogenic variants in KCTD7 perturb neuronal K+ fluxes and glutamine transport.

Moen MN, Fjær R, Hamdani EH, Laerdahl JK, Menchini RJ, Vigeland MD, Sheng Y, Undlien DE, Hassel B, Salih MA, El Khashab HY, Selmer KK, Chaudhry FA.

Brain. 2016 Dec;139(Pt 12):3109-3120. Epub 2016 Oct 14.

PubMed [citation]
PMID:
27742667
See all PubMed Citations (3)

Details of each submission

From Ambry Genetics, SCV003556778.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The c.550C>T (p.R184C) alteration is located in exon 4 (coding exon 4) of the KCTD7 gene. This alteration results from a C to T substitution at nucleotide position 550, causing the arginine (R) at amino acid position 184 to be replaced by a cysteine (C). Based on data from gnomAD, the T allele has an overall frequency of 0.002% (5/251302) total alleles studied. The highest observed frequency was 0.012% (4/34570) of Latino alleles. This variant has been identified in the homozygous state in multiple individuals with features consistent with KCTD7-related progressive myoclonus epilepsy (Staropoli, 2012; Monies, 2019). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024